|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
04/12/2024 |
$62.40 |
$62.40 |
$61.08 |
$61.33 |
2.00K | 04/15/2024 |
$61.60 |
$61.60 |
$60.65 |
$60.73 |
12.40K | 04/16/2024 |
$61.09 |
$61.09 |
$60.74 |
$60.74 |
3.70K | 04/17/2024 |
$60.92 |
$60.92 |
$60.56 |
$60.56 |
5.50K | 04/18/2024 |
$60.51 |
$60.51 |
$59.60 |
$59.62 |
8.10K |
|
PowerShares Dynamic Biotech & Genome Portfolio is an open-end management investment company. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Biotechnology & Genome Intellidex Index (the Index). The Index consists of stocks of 30 United States biotechnology and genome companies. These are companies that are principally engaged in the research, development, manufacture, and marketing and distribution of various biotechnological products, services and processes. As of Apr 30 2013, the Fund's total assets were $157,068,804and the Fund's investments portfolio was valued at $155,655,581. | |
|
Invesco Exchange-Traded Fund Trust - Biotechnology and Genome ETF (PBE) has the following price history information. Looking back at PBE historical stock prices for the last five trading days, on April 12, 2024, PBE opened at $62.40, traded as high as $62.40 and as low as $61.08, and closed at $61.33. Trading volume was a total of 2.00K shares. On April 15, 2024, PBE opened at $61.60, traded as high as $61.60 and as low as $60.65, and closed at $60.73. Trading volume was a total of 12.40K shares. On April 16, 2024, PBE opened at $61.09, traded as high as $61.09 and as low as $60.74, and closed at $60.74. Trading volume was a total of 3.70K shares. On April 17, 2024, PBE opened at $60.92, traded as high as $60.92 and as low as $60.56, and closed at $60.56. Trading volume was a total of 5.50K shares. On April 18, 2024, PBE opened at $60.51, traded as high as $60.51 and as low as $59.60, and closed at $59.62. Trading volume was a total of 8.10K shares.
PBE Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Invesco Exchange-Traded Fund Trust - Biotechnology and Genome ETF shares, starting with a $10,000 purchase of PBE, and working forward through the historical stock price information to today.
Growth of $10,000.00
With Dividends Reinvested
|
Start date: |
04/22/2014 |
|
End date: |
04/18/2024 |
|
Start price/share: |
$40.79 |
|
End price/share: |
$59.62 |
|
Starting shares: |
245.16 |
|
Ending shares: |
252.16 |
|
Dividends reinvested/share: |
$1.33 |
|
Total return: |
50.34% |
|
Average Annual Total Return: |
4.16% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$15,030.08 |
|
Years: |
10.00 |
|
|
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/22/2014 |
|
End date: |
04/18/2024 |
|
Start price/share: |
$40.79 |
|
End price/share: |
$59.62 |
|
Dividends collected/share: |
$1.33 |
|
Total return: |
49.43% |
|
Average Annual Total Return: |
4.10% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$14,943.75 |
|
Years: |
10.00 |
|
|
|
Date |
Close |
04/12/2024 | $61.33 | 04/15/2024 | $60.73 | 04/16/2024 | $60.74 | 04/17/2024 | $60.56 | 04/18/2024 | $59.62 |
|
|